Listing 1 - 10 of 27 | << page >> |
Sort by
|
Choose an application
The benefit of cohort studies and registers in patient-oriented collaborative research depends largely on the quality of the data recorded there. Supply and quality research depend on scientifically proven methods and procedures to ensure high data quality. This guideline contains corresponding recommendations for the management of data quality in registers, cohort studies and data repositories. In the second edition, a significantly expanded set of indicators is provided and the use of the indicators is described as an example for different types of empirical research projects. The guideline is rounded off by a current literature review and analysis. It is therefore an important part of the range of measures to improve and ensure data quality in medical research.
Medicine --- Research --- Methodology. --- Health Workforce --- Epidemiology & medical statistics --- data repository --- source data verification --- cohort study --- quality indicators
Choose an application
Health status indicators --- Lifestyles --- Mortality --- Health surveys --- Health Surveys --- Health aspects --- Mortality. --- Cohort Studies. --- Life Style. --- Health Surveys. --- -Health surveys --- -Japanese --- -Lifestyles --- -Life style --- Life styles --- Styles, Life --- Human behavior --- Manners and customs --- Ethnology --- Public health surveys --- Surveys --- Health indicators --- Health status indexes --- Indexes, Health status --- Indicators, Health status --- Health --- Medical statistics --- Public health --- Quality of life --- Social indicators --- Abortion Surveys --- Abortion Survey --- Health Survey --- Survey, Abortion --- Survey, Health --- Surveys, Abortion --- Surveys, Health --- Life Style Induced Illness --- Lifestyle --- Life Styles --- Quality of Life --- Social Environment --- Analysis, Cohort --- Cohort Studies, Closed --- Cohort Studies, Historical --- Studies, Closed Cohort --- Studies, Concurrent --- Studies, Historical Cohort --- Closed Cohort Studies --- Cohort Analysis --- Concurrent Studies --- Historical Cohort Studies --- Incidence Studies --- Analyses, Cohort --- Closed Cohort Study --- Cohort Analyses --- Cohort Study --- Cohort Study, Closed --- Cohort Study, Historical --- Concurrent Study --- Historical Cohort Study --- Incidence Study --- Studies, Cohort --- Studies, Incidence --- Study, Closed Cohort --- Study, Cohort --- Study, Concurrent --- Study, Historical Cohort --- Study, Incidence --- Age Specific Death Rate --- Age-Specific Death Rate --- Case Fatality Rate --- Decline, Mortality --- Determinants, Mortality --- Differential Mortality --- Excess Mortality --- Mortality Decline --- Mortality Determinants --- Mortality Rate --- Mortality, Differential --- Mortality, Excess --- Death Rate --- Age-Specific Death Rates --- Case Fatality Rates --- Death Rate, Age-Specific --- Death Rates --- Death Rates, Age-Specific --- Declines, Mortality --- Determinant, Mortality --- Differential Mortalities --- Excess Mortalities --- Mortalities --- Mortalities, Differential --- Mortalities, Excess --- Mortality Declines --- Mortality Determinant --- Mortality Rates --- Rate, Age-Specific Death --- Rate, Case Fatality --- Rate, Death --- Rate, Mortality --- Rates, Age-Specific Death --- Rates, Case Fatality --- Rates, Death --- Rates, Mortality --- Disease --- -Methodology --- mortality --- Japan. --- -Mortality --- -Japan. --- Cohort Studies --- Life Style --- Mortality, Law of --- Death --- Demography --- Death (Biology) --- Life style --- Methodology --- Bonin Islands --- CFR Case Fatality Rate --- Crude Death Rate --- Crude Mortality Rate --- Crude Death Rates --- Crude Mortality Rates --- Death Rate, Crude --- Mortality Rate, Crude --- Rate, Crude Death --- Rate, Crude Mortality --- Lifestyle Factors --- Factor, Lifestyle --- Lifestyle Factor --- Sanitary Surveys, Water Supply --- Health status indicators - Japan --- Lifestyles - Health aspects - Japan --- Mortality - Japan --- Health surveys - Japan --- Health Surveys - Japan
Choose an application
The impact of fat intake on hypercholesterolemia and related atherosclerotic cardiovascular diseases has been studied for decades. However, the current evidence base suggests that fatty acids also influences cardiometabolic diseases through other mechanisms including effects on glucose metabolism, body fat distribution, blood pressure, inflammation, and heart rate. Furthermore, studies evaluating single fatty acids have challenged the simplistic view of shared health effects within fatty acid groups categorized by degree of saturation. In addition, investigations of endogenous fatty acid metabolism, including genetic studies of fatty acid metabolizing enzymes, and the identification of novel metabolically derived fatty acids have further increased the complexity of fatty acids’ health impacts. This Special Issue aims to include original research and up-to-date reviews on genetic and dietary modulation of fatty acids, and the role and function of dietary and metabolically derived fatty acids in cardiometabolic health.
coronary artery disease --- n-6 fatty acids --- ischemic heart disease --- n-3 fatty acids --- body weight --- alternatively activated macrophages --- type 2 cytokines --- children --- medium-chain triglyceride --- fat --- omega-3 PUFA --- substitution models --- obesity --- EETs --- arachidonic acid --- blood pressure --- Genome-wide association study (GWAS) --- antioxidant --- Mediterranean diet --- Insulin sensitivity --- PUFA --- n-3 PUFA --- long-chain triglyceride --- fish oil --- omega 3 --- CAD --- adipose tissue --- FADS --- blood lipids --- hemodynamics --- genotype --- erucic acid --- klotho --- CYP450 eicosanoids --- cardiometabolic disease --- fibrosis --- desaturase --- EEQs --- cohort study --- lipid metabolism --- fatty acid --- metabolic disease --- epidemiology --- omega-3 --- inflammation --- docosapentaenoic acid --- omega-6 PUFA --- type 2 diabetes mellitus --- diet --- CKD --- human --- perivascular adipose tissue --- seafood --- cardiovascular disease --- prospective cohort study --- linoleic acid --- low-fat diet --- conjugated fatty acids --- furan fatty acids --- unsaturated fat --- statins --- fish --- cholesterol ester --- CHD --- COPD
Choose an application
In the last century, the average life expectancy at birth increased from roughly 45 years in the early 1900s to more than 80 years of age at present. However, living longer is often related to different levels of frailty. There is no curative treatment for frailty—the interventions that have been described as effective to slow or delay the onset of frailty are physical activity and nutritional interventions. Maintaining adequate nutrition status is important to reduce the risk of chronic diseases, many of which are age-related. On the other hand, frailty itself may have a negative effect on eating and, thus, on the nutritional status. This Special Issue, "Nutrition, Diet Quality, Aging and Frailty", addresses the existing knowledge on nutrition regarding the causative factors of frailty and disease due to aging, i.e., strategies for delaying the pathological effects of aging. It consists of twelve peer-reviewed papers covering original research, protocol development, methodological studies, narrative or systematic reviews, and meta-analyses, to better understand these complex relationships.
Medicine --- diet --- metabolism --- nutrient --- glucose --- lipid --- insulin --- neuroinflammation --- Alzheimer’s disease --- anti-ageing --- eating habits --- functional foods --- skin ageing --- breakfast --- meals --- older adults --- protein intake --- hyperhomocysteinemia --- vitamin B deficiency --- amyloid beta-peptides --- disease models --- animal --- memory and learning tests --- dietary diversity --- activities of daily living --- cohort study --- adults --- mortality --- QOL --- ADL --- Serum albumin --- self-assessed chewing ability --- inflammaging --- cognitive impairment --- cytokines --- physical frailty --- aged --- dietary inflammatory index --- dietary patterns --- frailty --- inflammation --- muscle function --- muscle mass --- sarcopenia --- prevalence --- nutrition --- physical activity --- meta-analysis --- meta-regression --- dairy products --- dietary pattern --- malnutrition --- food groups --- Mediterranean dietary pattern --- Westernized dietary pattern --- cross-sectional study --- aging --- lifespan --- carbohydrates --- whole grain --- protein
Choose an application
Gestational diabetes mellitus (GDM) is one of the most common adverse medical conditions that occurs during pregnancy, and its prevalence is rising as part of a diabetes pandemic. Nutrition plays a key role in GDM, whether (1) as part of an ‘unhealthy’ diet, which contributes to its cause, or (2) as part of changes in dietary intake, which act as the frontline treatment for GDM (sometimes supplemented with exercise and pharmacological intervention). Dietary changes, therefore, can alter the risk of developing GDM in the first place, and once GDM has emerged during pregnancy, dietary changes can mitigate the risk of developing GDM-related complications, such as macrosomia, respiratory distress, hypoglycemia and jaundice in the neonate, pre eclampsia, increased need for caesarean section and placental abruption in the mother. In this Special Issue, we aim to highlight the role of nutrition in the aetiology of GDM, whether directly or indirectly through weight gain and obesity, and in its role as a GDM treatment to lower hyperglycemia and the risk of the aforementioned complications.
microbiome --- pregnancy --- obesity --- ketonuria --- Roseburia --- diet --- food frequency questionnaire --- glucose --- insulin secretion --- human milk --- breastfeeding --- gestational diabetes mellitus --- insulin-dependent diabetes mellitus --- preterm newborn --- gestational diabetes --- dietary patterns --- maternal nutrition --- dietary adaptations --- glycemic index --- postprandial glycemic response --- blood glucose prediction --- diabetes --- gestational weight gain --- macrosomia --- adiposity --- neonate --- exercise --- physical activity --- dietary carbohydrates --- diabetes-specific formula --- continuous glucose monitoring --- glycemic variability --- carbohydrate distribution --- mean amplitude of glucose --- breakfast diet --- platelet-activating factor --- tumor necrosis factor α --- methylglyoxal --- glycated albumin --- endocrine disruptors --- endocrine-disrupting chemicals --- bisphenol A --- BPA --- phthalates --- pregnancy outcomes --- eating speed --- cohort study --- prevention --- nutrition --- polyphenolic compounds --- bioactive compounds --- leptin resistance --- inflammation --- Mediterranean diet --- n/a
Choose an application
Disorders of the central and peripheral nerve systems have severe effects on gut function. Hence, people who have sustained spinal cord injury and multiple sclerosis, Parkinson’s disease, or spina bifida patients may suffer from severe bowel symptoms, including constipation, incontinence to stools, difficult bowel evacuation, or pain. For the present book, a number of international experts have described how disorders of the nerve system affect bowel function, how to assess and treat bowel symptoms, and how the bacterial composition of the bowel may be affected.
laxatives --- constipation --- adults --- prevalence --- utilisation --- gut microbiota --- spina bifida --- transanal irrigation --- urinary tract infection --- SCI --- MENTOR --- NBD --- fecal incontinence --- Parkinson’s disease --- autonomic --- gastrointestinal --- alpha-synuclein --- parasympathetic --- neurogenic bowel dysfunction --- low anterior resection syndrome --- faecal incontinence --- chronic constipation --- bowel dysfunction --- quality of life --- spinal cord injury --- multiple sclerosis --- pharmacological --- systematic review --- neurogenic bowel --- treatment assessment --- bowel function --- exoskeletal walking --- difficulty with evacuation --- neostigmine --- glycopyrrolate --- iontophoresis --- autonomic dysfunction --- motility --- investigations --- manometry --- breath test --- imaging --- diabetes mellitus --- postprandial hypotension --- food ingestion --- ambulatory blood pressure measurement --- cohort study --- pediatric --- children --- adolescent --- anorectal malformation --- cerebral palsy --- acute rehabilitation --- opioids --- SCI bowel management
Choose an application
Gestational diabetes mellitus (GDM) is one of the most common adverse medical conditions that occurs during pregnancy, and its prevalence is rising as part of a diabetes pandemic. Nutrition plays a key role in GDM, whether (1) as part of an ‘unhealthy’ diet, which contributes to its cause, or (2) as part of changes in dietary intake, which act as the frontline treatment for GDM (sometimes supplemented with exercise and pharmacological intervention). Dietary changes, therefore, can alter the risk of developing GDM in the first place, and once GDM has emerged during pregnancy, dietary changes can mitigate the risk of developing GDM-related complications, such as macrosomia, respiratory distress, hypoglycemia and jaundice in the neonate, pre eclampsia, increased need for caesarean section and placental abruption in the mother. In this Special Issue, we aim to highlight the role of nutrition in the aetiology of GDM, whether directly or indirectly through weight gain and obesity, and in its role as a GDM treatment to lower hyperglycemia and the risk of the aforementioned complications.
Research & information: general --- Biology, life sciences --- Food & society --- microbiome --- pregnancy --- obesity --- ketonuria --- Roseburia --- diet --- food frequency questionnaire --- glucose --- insulin secretion --- human milk --- breastfeeding --- gestational diabetes mellitus --- insulin-dependent diabetes mellitus --- preterm newborn --- gestational diabetes --- dietary patterns --- maternal nutrition --- dietary adaptations --- glycemic index --- postprandial glycemic response --- blood glucose prediction --- diabetes --- gestational weight gain --- macrosomia --- adiposity --- neonate --- exercise --- physical activity --- dietary carbohydrates --- diabetes-specific formula --- continuous glucose monitoring --- glycemic variability --- carbohydrate distribution --- mean amplitude of glucose --- breakfast diet --- platelet-activating factor --- tumor necrosis factor α --- methylglyoxal --- glycated albumin --- endocrine disruptors --- endocrine-disrupting chemicals --- bisphenol A --- BPA --- phthalates --- pregnancy outcomes --- eating speed --- cohort study --- prevention --- nutrition --- polyphenolic compounds --- bioactive compounds --- leptin resistance --- inflammation --- Mediterranean diet
Choose an application
Disorders of the central and peripheral nerve systems have severe effects on gut function. Hence, people who have sustained spinal cord injury and multiple sclerosis, Parkinson’s disease, or spina bifida patients may suffer from severe bowel symptoms, including constipation, incontinence to stools, difficult bowel evacuation, or pain. For the present book, a number of international experts have described how disorders of the nerve system affect bowel function, how to assess and treat bowel symptoms, and how the bacterial composition of the bowel may be affected.
Medicine --- Neurology & clinical neurophysiology --- laxatives --- constipation --- adults --- prevalence --- utilisation --- gut microbiota --- spina bifida --- transanal irrigation --- urinary tract infection --- SCI --- MENTOR --- NBD --- fecal incontinence --- Parkinson’s disease --- autonomic --- gastrointestinal --- alpha-synuclein --- parasympathetic --- neurogenic bowel dysfunction --- low anterior resection syndrome --- faecal incontinence --- chronic constipation --- bowel dysfunction --- quality of life --- spinal cord injury --- multiple sclerosis --- pharmacological --- systematic review --- neurogenic bowel --- treatment assessment --- bowel function --- exoskeletal walking --- difficulty with evacuation --- neostigmine --- glycopyrrolate --- iontophoresis --- autonomic dysfunction --- motility --- investigations --- manometry --- breath test --- imaging --- diabetes mellitus --- postprandial hypotension --- food ingestion --- ambulatory blood pressure measurement --- cohort study --- pediatric --- children --- adolescent --- anorectal malformation --- cerebral palsy --- acute rehabilitation --- opioids --- SCI bowel management
Choose an application
Tea, made from the leaves of the Camellia senenisis plant, is the second most consumed beverage worldwide after water. Accumulating evidence from cellular, animal, epidemiological and clinical studies have linked tea consumption to various health benefits, such as chemoprevention of cancers, chronic inflammation, heart and liver diseases, diabetes, neurodegenerative diseases, etc. Although such health benefits have not been consistently observed in some intervention trials, positive results from clinical trials have provided direct evidence supporting the cancer-protective effect of green tea. In addition, numerous mechanisms of action have been suggested to contribute to tea’s disease-preventive effects. Furthermore, effects of the processing and storage of tea, as well as additives on tea’s properties have been investigated.
polyphenols --- n/a --- cell cycle arrest and apoptosis --- neuroblastoma --- salivary ?-amylase activity --- cancer apoptosis --- yaupon holly --- bioaccessibility --- fracture --- p53 --- tea --- Liubao tea --- BE(2)-C --- matrix metalloproteinase-1 (MMP-1) --- catechin --- renal stone --- oxalate --- protein expression --- 67LR --- Alzheimer’s disease --- EGCG --- nutraceutical --- diseases --- anti-oxidant --- heme oxygenase-1 --- polyphenol --- anxiety --- matcha --- ERCC1/XPF --- neuro-sphere --- tea consumption --- theanine --- Rosmarinic acid --- yerba mate --- hypercalciuria --- gene expression --- microbiota --- cohort study --- histone deacetylase 2 (HDAC2) --- guayusa --- nuclear factor erythroid 2-related factor 2 (Nrf2) --- DNA repair --- mRNA expression --- caffeine --- chemoprevention --- cisplatin --- 6-OH-11-O-hydroxyphenanthrene --- adrenal hypertrophy --- hepatic damage --- anti-photoaging --- cell death --- green tea --- kudingcha --- suberoylanilide hydroxamic acid (SAHA) --- epigallocatechin gallate (EGCG) --- stress-reduction --- calcium oxalate monohydrate --- Camellia sinensis --- chemoresistance --- tea polyphenols --- green tea polyphenols --- green tea catechins --- N-MYC --- cancer --- epigallocatechin-gallate (EGCG) --- Parkinson’s disease --- Alzheimer's disease --- Parkinson's disease
Choose an application
The purpose of this Special Issue is to provide a thorough and up-to-date presentation of research investigating the impact of coffee and/or caffeine intake on various health outcomes. Areas of interest include, but are not limited to, the following topics: Human clinical trials of coffee or caffeine use in relation to disease or intermediate phenotypes. Epidemiological studies of habitual coffee or caffeine intake in relation to human health, among the general public, as well as, among special populations (i.e., children, pregnant women, diabetics, cancer patients, hypertensives, etc.). Mechanisms of action of nutrients and other bioactive components of coffee/caffeine. Studies integrating genetic or physiological markers of coffee/caffeine intake to investigations of coffee and health.
coronary artery disease --- n/a --- lipids --- NADH dehydrogenase --- tea --- tinnitus --- safety --- transcriptomics --- ergogenic --- guidelines --- myocardial perfusion --- placebo --- Caffeine --- risk factors --- lysophosphatidylcholine --- pregnancy --- assisted reproduction techniques --- population --- adenosine --- liver fibrosis --- coffee consumption --- cognitive --- causation --- supplement --- mate --- adult --- gene expression --- wine --- lipidomics --- chocolate --- exercise --- protection --- Suicide --- dipyridamole --- regadenoson --- live birth --- hearing --- pharmacological ergogenic aid --- behavior --- cardiovascular disease --- gene-diet interaction --- whole-blood --- sex --- health --- systematic review --- causality --- genetic epidemiology --- implantation --- pharmacogenomics --- cognitions --- ergogenic aid --- time trial performance --- CYP1A2 --- aging --- phenolic --- country --- caffeine intake --- serum chloride levels --- polymorphism --- responders --- intoxication --- trial --- epidemiological methods --- bias --- adenosine receptor --- longevity --- did not respond --- energy drinks --- biomarkers --- individual responses --- Mendelian Randomization --- public policy --- anxiety --- the Norwegian Women and Cancer Cohort (NOWAC) --- ADORA2A --- clinical pregnancy --- caffeine metabolism --- caffeine intoxication --- cohort study --- mood --- mRNA --- alcohol consumption --- epidemiology --- caffeine --- expectancy --- accidental death --- European Prospective Investigation into Cancer and Nutrition --- cognition --- consumption --- HIV-HCV co-infection --- cytochrome P450 --- chlorogenic acids --- soda --- 24-h dietary recall --- coffee --- depression --- sport --- age
Listing 1 - 10 of 27 | << page >> |
Sort by
|